课题基金 / 基金详情

The Hematopoietic Kinome

The Hematopoietic Kinome
造血激酶组
批准号:
7140293
负责人:
William Garrow Kerr
金额:
$18.22万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-30 至 2007-08-31

项目摘要

项目成果

William Garrow Kerr的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Over the last 2 years array and mass spectrometry technologies have enabled analysis of the transcriptome and proteome of hematopoietic stem cells (HSC) and their downstream progenitors. This information will be of significant value to the elucidation of molecular mechanisms that govern stem cell physiology and blood cell differentiation. However, an equally, if not more important goal, is to define those proteins that participate in signaling pathways that are active in hematopoietic stem cells and their progeny. Enzymes that phosphorylate tyrosine, serine and threonine residues on other proteins play a major role in signaling cascades that determine cell cycle entry, survival and the differentiation fate of cells in the mammalian body, including the hematopoietic system. In particular, knowing the signaling pathways that are active in HSC and their differentiated progeny will provide critical information for understanding stem cell biology and cell differentiation. Traditional genetic and biochemical approaches can certainly provide some of these answers; however, for technical and practical reasons, these are typically pursued one gene or pathway at a time. Thus, a more comprehensive approach is needed in order to reveal signaling pathways active in HSC and their differentiated progeny. Towards this end, we have developed kinome analysis techniques and begun to apply them to HSC and differentiated progenitor cell types. In this study, we propose to provide a comprehensive analysis of the HSC kinome and their more differentiated progeny as this will further define our understanding of the signaling pathways utilized during different stages of hematopoietic development. This proposal will be pursued in the following specific aims: Aim 1: Compare and contrast the kinome of LT-HSC and ST-HSC populations during steady-state hematopoiesis. Aim 2: Determine the LT-HSC kinome during expansion of the hematopoietic compartment. Aim 3: Determine the kinome of key multi-potent progenitors and lineage-restricted progenitor cell types.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation
  • 批准号:
    8211010
  • 项目类别:
  • 资助金额:
    $41.32万
  • 财政年份:
    2011
  • 负责人:
    William Garrow Kerr
  • 依托单位:
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation
  • 批准号:
    8588988
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2011
  • 负责人:
    William Garrow Kerr
  • 依托单位:
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation
  • 批准号:
    8425109
  • 项目类别:
  • 资助金额:
    $39.09万
  • 财政年份:
    2011
  • 负责人:
    William Garrow Kerr
  • 依托单位:
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation
  • 批准号:
    8064489
  • 项目类别:
  • 资助金额:
    $42.76万
  • 财政年份:
    2011
  • 负责人:
    William Garrow Kerr
  • 依托单位:
国内基金
海外基金
雷特综合症致病蛋白MeCP2在DNA损伤修复中的功能及分子机制研究
  • 批准号:
    32070780
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    刘红美
  • 依托单位:
组蛋白去乙酰化酶SirT7翻译后修饰及其在调控肿瘤耐药中的作用研究
  • 批准号:
    32070770
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    孙莲慧
  • 依托单位:
新的FANCM关联蛋白复合物FMAP150-FMAP160调控FANCM修复停滞复制叉的作用及机制
  • 批准号:
    32070716
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    ZHIJIANG YAN
  • 依托单位:
激活SENP1-Sirt3轴改善线粒体健康对延缓衰老的作用与机制研究
  • 批准号:
    92049113
  • 项目类别:
    重大研究计划
  • 资助金额:
    60.0万元
  • 批准年份:
    2020
  • 负责人:
    王田实
  • 依托单位: